Beneficial action of resveratrol: How and why?

Nutrition

Volumn 32, Issue 2, 2016, Pages 174-178

  Diaz Gerevini, Gustavo Tomas ^a   Repossi, Gaston ^a,b,c   Dain, Alejandro ^a   Tarres, María Cristina ^c,d   Das, Undurti Narasimha ^e,f   Eynard, Aldo Renato ^a,c  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Universidad Nacional de La Rioja   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^d FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^e GAYATRI VIDYA PARISHAD COLLEGE OF ENGINEERING   (India)

^f UND Life Sciences   (United States)

Author keywords

Alzheimer's disease; Flavonoids; Microbiota; Obesity; Resveratrol; Type 2 diabetes mellitus

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 17; LIPOXIN A; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANTIOXIDANT; CYTOCHROME P450 1A1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXIN; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; VASCULOTROPIN A;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTISM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; FATTY ACID OXIDATION; GLUCONEOGENESIS; HUMAN; METABOLIC SYNDROME X; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; STEM CELL; T LYMPHOCYTE ACTIVATION; ANTAGONISTS AND INHIBITORS; AUTISTIC DISORDER; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GASTROINTESTINAL TRACT; GENETICS; INTESTINE FLORA; METABOLISM; MICROBIOLOGY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; APOPTOSIS; AUTISTIC DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOCHROME P-450 CYP1A1; DIABETES MELLITUS, TYPE 2; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERLEUKIN-17; LIPOXINS; METABOLIC SYNDROME X; NF-KAPPA B; STILBENES; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84955718745     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.08.017     Document Type: Review

References (58)

1. Knight J.A. Diseases and disorders associated with excess body weight. Ann Clin Lab Sci 2011, 41:107-121.
2. Hu F.B. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011, 34:1249-1257.
3. Lam D.W., LeRoith D. The worldwide diabetes epidemic. Curr Opin Endocrinol Diabetes Obes 2012, 19:93-96.
4. Yorimitsu T., Nair U., Yang Z., Klionsky D.J. Endoplasmic reticulum stress triggers autophagy. J Biol Chem 2006, 281:30299-30304.
5. Juárez-Rojas J.G., Reyes-Soffer G., Conlon D., Ginsberg H.N. Autophagy and cardiometabolic risk factors. Rev Endocr Metab Disord 2014, 15:307-315.
6. Stienstra R., Haim Y., Riahi Y., Netea M., Rudich A., Leibowitz G. Autophagy in adipose tissue and the beta cell: implications for obesity and diabetes. Diabetologia 2014, 57:1505-1516.
7. Yin J., Wang Y., Gu L., Fan N., Ma Y., Peng Y. Palmitate induces endoplasmic reticulum stress and autophagy in mature adipocytes: Implications for apoptosis and inflammation. Int J Mol Med 2015, 35:932-940.
8. Tan S.H., Shui G., Zhou J., Li J.J., Bay B.H., Wenk M.R., et al. Induction of autophagy by palmitic acid via protein kinase C-mediated signaling pathway independent of mTOR (mammalian target of rapamycin). J Biol Chem 2012, 287:14364-14376.
9. Alcaín F.J., Villalba J.M. Sirtuin activators. Expert Opin Ther Pat 2009, 19:403-414.
10. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 alpha. Cell 2006, 127:1109-1122.
11. Denu J.M. Fortifying the link between SIRT1, resveratrol, and mitochondrial function. Cell Metab 2012, 15:566-567.
12. Sajish M., Schimmel P. A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol. Nature 2015, 519:370-373.
13. Robb E.L., Page M.M., Wiens B.E., Stuart J.A. Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive inductionof MnSOD. Biochem Biophys Res Commun 2008, 367:406-412.
14. Stefani M., Markus M.A., Lin R.C., Pinese M., Dawes I.W., Morris B.J. The effect of resveratrol on a cell model of human aging. Ann N Y Acad Sci 2007, 1114:407-418.
15. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303:2011-2015.
16. Kops G.J., Dansen T.B., Polderman P.E., Saarloos I., Wirtz K.W., Coffer P.J., et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002, 419:316-321.
17. Khan M.A., Chen H.C., Wan X.X., Tania M., Xu A.H., Chen F.Z., et al. Regulatory effects of resveratrol on antioxidant enzymes: a mechanism of growth inhibition and apoptosis induction in cancer cells. Mol Cells 2013, 35:219-225.
18. Leiro J., Arranz J.A., Fraiz N., Sanmartín M.L., Quezada E., Orallo F., et al. Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling. Int Immunopharmacol 2005, 5:393-406.
19. Chun Y.J., Kim M.Y., Guengerich F.P. Resveratrol is a selective human cytochrome P450 1 A1 inhibitor. Biochem Biophys Res Commun 1999, 262:20-24.
20. Cao Y., Fu Z.D., Wang F., Liu H.Y., Han R. Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J Asian Nat Prod Res 2005, 7:205-213.
21. Hung L.M., Chen J.K., Huang S.S., Lee R.S., Su M.J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 2000, 47:549-555.
22. Pasinetti G.M., Wang J., Ho L., Zhao W., Dubner L. Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment. Biochim Biophys Acta 2015, 1852:1202-1208.
23. Tennen R.I., Michishita-Kioi E., Chua K.F. Finding a target for resveratrol. Cell 2012, 148:387-389.
24. Park S.J., Ahmad F., Philp A., Baar K., Williams T., Luo H., et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148:421-433.
25. H17 cells. Nature 2008, 453:1051-1057.
26. Margarita Dominguez-Villar M., Hafler D.A. An innate role for IL-17. Science 2011, 332:47-48.
27. Nakae S., Nambu A., Sudo K., Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003, 171:6173-6177.
28. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006, 177:566-573.
29. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003, 52:65-70.
30. Singh N.P., Hegde V.L., Hofseth L.J., Nagarkatti M., Nagarkatti P. Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol Pharmacol 2007, 72:1508-1521.
31. Imler T.J., Petro T.M. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression. Int Immunopharmacol 2009, 9:134-143.
32. Lanzilli G., Cottarelli A., Nicotera G., Guida S., Ravagnan G., Fuggetta M.P. Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 2012, 35:240-248.
33. Xuzhu G., Komai-Koma M., Leung B.P., Howe H.S., McSharry C., McInnes I.B., et al. Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann Rheum Dis 2012, 71:129-135.
34. Kjær T.N., Thorsen K., Jessen N., Stenderup K., Pedersen S.B. Resveratrol ameliorates imiquimod-induced psoriasis-like skin inflammation in mice. PLoS One 2015, 10:E0126599.
35. Yao J., Wei C., Wang J.Y., Zhang R., Li Y.X., Wang L.S. Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice. World J Gastroenterol 2015, 21:6572-6581.
36. Zhang M., Li W., Yu L., Wu S. The suppressive effect of resveratrol on HIF-1α and VEGF expression after warm ischemia and reperfusion in rat liver. PLoS One 2014, 9:E109589.
37. Seong H., Ryu J., Jeong J.Y., Chung I.Y., Han Y.S., Hwang S.H., et al. Resveratrol suppresses vascular endothelial growth factor secretion via inhibition of CXC-chemokine receptor 4 expression in ARPE-19 cells. Mol Med Rep 2015, 12:1479-1484.
38. Trapp V., Parmakhtiar B., Papazian V., Willmott L., Fruehauf J.P. Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture. Angiogenesis 2010, 13:305-315.
39. Savastano S., Tarantino G., D'Esposito V., Passaretti F., Cabaro S., Liotti A., et al. Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population. J Transl Med 2015, 13:169.
40. Stein T.P., Schluter M.D., Steer R.A., Guo L., Ming X. Bisphenol A exposure in children with autism spectrum disorders. Autism Res 2015, 8:272-283.
41. Kundakovic M., Gudsnuk K., Herbstman J.B., Tang D., Perera F.P., Champagne F.A. DNA methylation of BDNF as a biomarker of early-life adversity. Proc Natl Acad Sci U S A 2015, 112:6807-6813.
42. Das U.N. Obesity: genes, brain, gut and environment. Nutrition 2010, 26:459-473.
43. Côté C.D., Rasmussen B.A., Duca F.A., Zadeh-Tahmasebi M., Baur J.A., Daljeet M., et al. Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network. Nat Med 2015, 21:498-505.
44. Duca F.A., Côté C.D., Rasmussen B.A., Zadeh-Tahmasebi M., Rutter G.A., Filippi B.M., et al. Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat Med 2015, 21:506-511.
45. Bambini-Junior V., Zanatta G., Della Flora Nunes G., Mueller de Melo G., Michels M., Fontes-Dutra M., et al. Resveratrol prevents social deficits in animal model of autism induced by valproic acid. Neurosci Lett 2014, 583:176-181.
46. Das U.N. Autism as a disorder of deficiency of brain-derived neurotrophic factor and altered metabolism of polyunsaturated fatty acids. Nutrition 2013, 29:1175-1185.
47. Kaviarasan K., Mohanlal J., Mohammad Mulla M.A., Shanmugam S., Sharma T., Das U.N., et al. Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance as potential risk factors for diabetic retinopathy. Metabolism 2015, 64:958-966.
48. 4 as possible anti-diabetic molecules. Prostaglandins Leukot Essent Fatty Acids 2013, 88:201-210.
49. Umashankar V., Sathya B.R., Kaviarasan K., Jithu M., Das U.N., Angayarkanni N. Agonistic effect of polyunsaturated fatty acids (PUFAs) and its metabolites on brain-derived neurotrophic factor (BDNF) through molecular docking simulation. Lipids Health Dis 2012, 11:109.
50. 2 production and estrogen signaling. PLoS One 2014, 9:E89742.
51. Sailaja P., Mani A.M., Naveen K.V., Anasuya D.H., Siresha B., Das U.N. Effect of polyunsaturated fatty acids and their metabolites on bleomycin-induced cytotoxic action on human neuroblastoma cells in vitro. PLoS One 2014, 9:E114766.
52. Qiao Y., Sun J., Xia S., Tang X., Shi Y., Le G. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Funct 2014, 5:1241-1249.
53. Chen Y.B., Lan Y.W., Hung T.H., Chen L.G., Choo K.B., Cheng W.T., et al. Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol promotes angiogenesis in a mouse model. Cell Stress Chaperones 2015, 20:643-652.
54. Pezzolla D., López-Beas J., Lachaud C.C., Domínguez-Rodríguez A., Smani T., Hmadcha A., et al. Resveratrol ameliorates the maturation process of β-cell-like cells obtained from an optimized differentiation protocol of human embryonic stem cells. PLoS One 2015, 10:E0119904.
55. Lee Y.L., Peng Q., Fong S.W., Chen A.C., Lee K.F., Ng E.H., et al. Sirtuin 1 facilitates generation of induced pluripotent stem cells from mouse embryonic fibroblasts through the miR-34 a and p53 pathways. PLoS One 2012, 7:E45633.
56. Cai H., Scott E., Kholghi A., Andreadi C., Rufini A., Karmokar A., et al. Cancer chemoprevention: evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci Transl Med 2015, 7:298 ra117.
57. Penalva R., Esparza I., Larraneta E., González-Navarro C.J., Gamazo C., Irache J.M. Zein-based nanoparticles improve the oral bioavailability of resveratrol and its anti-inflammatory effects in a mouse model of endotoxic shock. J Agric Food Chem 2015, 63:5603-5611.
58. da Rocha Lindner G., Bonfanti Santos D., Colle D., Gasnhar Moreira E.L., Daniel Prediger R., Farina M., et al. Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism. Nanomedicine (Lond) 2015, 10:1127-1138.